TKG Advisors’s ResMed RMD Stock Holding History

TKG Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,286	Closed	-$513K	–	104
2026 Q1	$513K	Sell	2,286 -72	-3%	-$17.9K	0.21%	71
2025 Q4	$568K	Buy	2,358 +128	+6%	+$32.7K	0.23%	66
2025 Q3	$610K	Buy	2,230 +88	+4%	+$24K	0.26%	61
2025 Q2	$553K	Sell	2,142 -74	-3%	-$17.7K	0.25%	58
2025 Q1	$496K	Buy	+2,216	New	+$517K	0.24%	59

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TKG Advisors's RMD Position: Q2 2026 in Review

TKG Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,286 shares — an estimated $513K sold.

TKG Advisors first reported a position in RMD in Q1 2025 and held it in 5 quarters. The position peaked at $610K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

TKG Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
TKG Advisors sold 2,286 ResMed shares in Q2 2026, an estimated $513K.
TKG Advisors first reported a position in ResMed in Q1 2025 and held it in 5 quarters.
TKG Advisors's ResMed position peaked at $610K in Q3 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on TKG Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.